| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 178.730 | 183.924 | 203.813 | 209.449 | 206.540 | 207.478 | 216.072 | 270.006 | 282.098 | 336.825 |
| Total Income - EUR | 181.061 | 184.856 | 204.110 | 209.639 | 206.554 | 207.518 | 216.266 | 270.575 | 283.163 | 338.426 |
| Total Expenses - EUR | 167.551 | 175.783 | 192.212 | 206.925 | 200.406 | 191.879 | 204.678 | 252.586 | 258.540 | 320.991 |
| Gross Profit/Loss - EUR | 13.509 | 9.073 | 11.898 | 2.715 | 6.148 | 15.639 | 11.588 | 17.989 | 24.622 | 17.434 |
| Net Profit/Loss - EUR | 11.348 | 7.621 | 9.886 | 620 | 4.188 | 13.770 | 9.526 | 15.689 | 22.418 | 8.799 |
| Employees | 3 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 5 |
Check the financial reports for the company - Medofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.437 | 18.871 | 18.549 | 16.422 | 14.441 | 12.771 | 11.282 | 10.106 | 8.870 | 9.664 |
| Current Assets | 53.991 | 44.373 | 63.936 | 68.176 | 63.988 | 64.213 | 73.668 | 85.634 | 110.193 | 112.277 |
| Inventories | 25.162 | 31.615 | 31.066 | 28.152 | 31.243 | 29.891 | 31.675 | 46.915 | 51.489 | 51.998 |
| Receivables | 21.400 | 4.415 | 26.157 | 28.361 | 23.014 | 29.593 | 36.302 | 32.649 | 30.530 | 41.226 |
| Cash | 7.429 | 8.343 | 6.713 | 11.664 | 9.731 | 4.729 | 5.691 | 6.070 | 28.174 | 19.053 |
| Shareholders Funds | 20.798 | 20.986 | 23.075 | 23.271 | 12.258 | 21.661 | 30.707 | 30.269 | 52.595 | 47.216 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 47.630 | 42.258 | 59.410 | 61.328 | 66.171 | 55.323 | 54.243 | 65.471 | 66.468 | 74.725 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Medofarm S.r.l.